Hana Pálová, Ph.D.

Publications that are part of the Web of Science database, possibly also other publications chosen by authors.

2021

• Papez, J; Starha, J; Zerhau, P; Pavlovska, D; Jezova, M; Jurencak, T; Slaba, K; Sterba, M; Kerekes, A; Merta, T; Haluskova, T; Palova, H; Slaby, O; Sterba, J; Jabandziev, P, 2021: Spindle Cell Hemangioma and Atypically Localized Juxtaglomerular Cell Tumor in a Patient with Hereditary BRIP1 Mutation: A Case Report. GENES 12(2), doi: 10.3390/genes12020220

2020

• Noskova, H; Kyr, M; Pal, K; Merta, T; Mudry, P; Polaskova, K; Ivkovic, TC; Adamcova, S; Hornakova, T; Jezova, M; Kren, L; Sterba, J; Slaby, O, 2020: Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?. CANCERS 12(1), doi: 10.3390/cancers12010230
• Polaskova, K; Merta, T; Martincekova, A; Zapletalova, D; Kyr, M; Mazanek, P; Krenova, Z; Mudry, P; Jezova, M; Tuma, J; Skotakova, J; Cervinkova, I; Valik, D; Zdrazilova-Dubska, L; Noskova, H; Pal, K; Slaby, O; Fabian, P; Kozakova, S; Neradil, J; Veselska, R; Kanderova, V; Hrusak, O; Freiberger, T; Klement, GL; Sterba, J, 2020: Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside. FRONTIERS IN ONCOLOGY 9, doi: 10.3389/fonc.2019.01531
• Slaba, K; Noskova, H; Vesela, P; Tuckova, J; Jicinska, H; Honzik, T; Hansikova, H; Kleiblova, P; Stourac, P; Jabandziev, P; Slaby, O; Prochazkova, D, 2020: Novel Splicing Variant in the PMM2 Gene in a Patient With PMM2-CDG Syndrome Presenting With Pericardial Effusion: A Case Report. FRONTIERS IN GENETICS 11, doi: 10.3389/fgene.2020.561054

2018

• Melicharkova, K; Martincekova, A; Zapletalova, D; Kyr, M; Mazanek, P; Krenova, Z; Mudry, P; Tuma, J; Skotakova, J; Cervinkova, I; Valik, D; Zdrazilova-Dubska, L; Noskova, H; Pal, K; Slaby, O; Fabian, P; Kozakova, S; Neradil, J; Veselska, R; Kanderova, V; Hrusak, O; Freiberger, T; Klement, GL; Sterba, J, 2018: Customized, or randomized trials for relapsed refractory pediatric Burkitt lymphomas? A retrospective analysis of two clinical cases with comprehensive molecular profiling - possible explanation for different treatment outcomes after similar targeted therapies. BRITISH JOURNAL OF HAEMATOLOGY 182, p. 97 - 98
• Rohleder, O; Mudry, P; Neradil, J; Noskova, H; Slaby, O; Sterba, J, 2018: Letter to Editor: FS Kaplan, et al., Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017). BONE 116, p. 171 - 171, doi: 10.1016/j.bone.2018.08.003
• Sramek, M; Neradil, J; Macigova, P; Mudry, P; Polaskova, K; Slaby, O; Noskova, H; Sterba, J; Veselska, R, 2018: Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 19(9), doi: 10.3390/ijms19092599

2016

• Buckova, H; Noskova, H; Borska, R; Reblova, K; Pinkova, B; Zapletalova, E; Kopeckova, L; Horky, O; Nemeckova, J; Gaillyova, R; Nagy, Z; Vesely, K; Hermanova, M; Stehlikova, K; Fajkusova, L, 2016: Autosomal recessive congenital ichthyoses in the Czech Republic. BRITISH JOURNAL OF DERMATOLOGY 174(2), p. 405 - 407, doi: 10.1111/bjd.13918

• Národní centrum lékařské genomiky (LM2015091), Ministerstvo školství, mládeže a tělovýchovy ČR, 2016 - 2019
• Analysis of EGFR signalling and microRNA expression profiles in prediction of response to anti-EGFR (NT/13860), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• MicroRNA analysis in glioblastoma stem cells: prediction of therapy response and identification of new therapeutic targets in glioblastoma patients (NT/13514), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Complex characterization of molecular genetic changes in glioblastoma multiforme and its relapses, and evaluation of their possible significance in oncologic therapy and therapy effect (NT/13581), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Studium mikroRNA a genů asociovaných s procesem epiteliálně-mezenchymální tranzice jako potenciálních markerů pro predikci rizika a časný záchyt metastazování u pacientů s renálním karcinomem (NT13547-4/2012), Ministry of Health of the CR, 2012 - 2015
• Development of diagnostic panel of circulating microRNAs for non-invasive early diagnostics and follow-up of colorectal cancer patients (NT/13549), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Development of microRNA diagnostic panel for identification Barret esophagus patients at high-risk of progression to adenocarcinoma (NT13585), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2014
• Identification and functional characterization of microRNAs with predictive significance in patients with glioblastoma (NT/11214), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2013